This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Dose determination of Taxotere�, Eloxatin� and Xel...
Clinical trial

Dose determination of Taxotere�, Eloxatin� and Xeloda� (TEX) in combination with Herpectin� as first line treatment to patients with HER2-positive non-resectable esophagus, cardia or gastric cancer

Read time: 1 mins
Last updated:6th Dec 2010
To determine maximum tolerable dose (MTD) for the combination regime TEX (docetaxel, oxaliplatin and capecitabine) + trastuzumab and to evaluate the toxicity
Category Value
Study start date 2010-12-06

View full details